Results of retroviral and adenoviral approaches to cancer gene therapy.

L. H. Yin, S. Q. Fu, T. Nanakorn, F. Garcia-Sanchez, I. Chung, R. Cote, G. Pizzorno, E. Hanania, S. Heimfeld, Ronald Crystal, A. Deisseroth

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Genetic modification for cancer treatment has involved the introduction of chemotherapy protection and sensitization genes into normal and tumor cells, respectively, for the purpose of improving the outcome of conventional approaches to the treatment of solid tumor neoplasms. This paper will review the use of multidrug resistance-1 retroviral vectors and cytosine deaminase adenoviral prodrug activation vectors for this purpose.

Original languageEnglish
Pages (from-to)247-250
Number of pages4
JournalStem cells (Dayton, Ohio)
Volume16 Suppl 1
Publication statusPublished - 1 Dec 1998
Externally publishedYes

Fingerprint

Neoplasm Genes
Genetic Therapy
Neoplasms
Cytosine Deaminase
Prodrugs
Multiple Drug Resistance
Drug Therapy
Therapeutics
Genes

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Yin, L. H., Fu, S. Q., Nanakorn, T., Garcia-Sanchez, F., Chung, I., Cote, R., ... Deisseroth, A. (1998). Results of retroviral and adenoviral approaches to cancer gene therapy. Stem cells (Dayton, Ohio), 16 Suppl 1, 247-250.

Results of retroviral and adenoviral approaches to cancer gene therapy. / Yin, L. H.; Fu, S. Q.; Nanakorn, T.; Garcia-Sanchez, F.; Chung, I.; Cote, R.; Pizzorno, G.; Hanania, E.; Heimfeld, S.; Crystal, Ronald; Deisseroth, A.

In: Stem cells (Dayton, Ohio), Vol. 16 Suppl 1, 01.12.1998, p. 247-250.

Research output: Contribution to journalReview article

Yin, LH, Fu, SQ, Nanakorn, T, Garcia-Sanchez, F, Chung, I, Cote, R, Pizzorno, G, Hanania, E, Heimfeld, S, Crystal, R & Deisseroth, A 1998, 'Results of retroviral and adenoviral approaches to cancer gene therapy.', Stem cells (Dayton, Ohio), vol. 16 Suppl 1, pp. 247-250.
Yin LH, Fu SQ, Nanakorn T, Garcia-Sanchez F, Chung I, Cote R et al. Results of retroviral and adenoviral approaches to cancer gene therapy. Stem cells (Dayton, Ohio). 1998 Dec 1;16 Suppl 1:247-250.
Yin, L. H. ; Fu, S. Q. ; Nanakorn, T. ; Garcia-Sanchez, F. ; Chung, I. ; Cote, R. ; Pizzorno, G. ; Hanania, E. ; Heimfeld, S. ; Crystal, Ronald ; Deisseroth, A. / Results of retroviral and adenoviral approaches to cancer gene therapy. In: Stem cells (Dayton, Ohio). 1998 ; Vol. 16 Suppl 1. pp. 247-250.
@article{088572841b7b4f69acaf2ee0a082e9b2,
title = "Results of retroviral and adenoviral approaches to cancer gene therapy.",
abstract = "Genetic modification for cancer treatment has involved the introduction of chemotherapy protection and sensitization genes into normal and tumor cells, respectively, for the purpose of improving the outcome of conventional approaches to the treatment of solid tumor neoplasms. This paper will review the use of multidrug resistance-1 retroviral vectors and cytosine deaminase adenoviral prodrug activation vectors for this purpose.",
author = "Yin, {L. H.} and Fu, {S. Q.} and T. Nanakorn and F. Garcia-Sanchez and I. Chung and R. Cote and G. Pizzorno and E. Hanania and S. Heimfeld and Ronald Crystal and A. Deisseroth",
year = "1998",
month = "12",
day = "1",
language = "English",
volume = "16 Suppl 1",
pages = "247--250",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",

}

TY - JOUR

T1 - Results of retroviral and adenoviral approaches to cancer gene therapy.

AU - Yin, L. H.

AU - Fu, S. Q.

AU - Nanakorn, T.

AU - Garcia-Sanchez, F.

AU - Chung, I.

AU - Cote, R.

AU - Pizzorno, G.

AU - Hanania, E.

AU - Heimfeld, S.

AU - Crystal, Ronald

AU - Deisseroth, A.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Genetic modification for cancer treatment has involved the introduction of chemotherapy protection and sensitization genes into normal and tumor cells, respectively, for the purpose of improving the outcome of conventional approaches to the treatment of solid tumor neoplasms. This paper will review the use of multidrug resistance-1 retroviral vectors and cytosine deaminase adenoviral prodrug activation vectors for this purpose.

AB - Genetic modification for cancer treatment has involved the introduction of chemotherapy protection and sensitization genes into normal and tumor cells, respectively, for the purpose of improving the outcome of conventional approaches to the treatment of solid tumor neoplasms. This paper will review the use of multidrug resistance-1 retroviral vectors and cytosine deaminase adenoviral prodrug activation vectors for this purpose.

UR - http://www.scopus.com/inward/record.url?scp=0032227152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032227152&partnerID=8YFLogxK

M3 - Review article

C2 - 11012168

AN - SCOPUS:0032227152

VL - 16 Suppl 1

SP - 247

EP - 250

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

ER -